Autoimmune Disease Testing at IDC (ISO15189:2022 Accredited Laboratory) – Comprehensive Autoimmune Diagnostics Using Multiple Advanced Technologies
Autoimmune diseases often present with diverse and non-specific clinical manifestations, making accurate laboratory diagnosis essential. At Islamabad Diagnostic Centre (IDC), a comprehensive portfolio of autoimmune tests is available using a combination of Indirect Immunofluorescence Assay (IFA), Immunoblotting, Chemiluminescence Immunoassay (CLIA), and ELISA technologies on fully automated platforms. This multi-technology approach enables highly sensitive screening, accurate antibody identification, and reliable quantitative testing to support clinicians in diagnosing and monitoring autoimmune disorders.
Why IDC’s Autoimmune Testing is Different
Comprehensive autoimmune testing using IFA, Immunoblotting, CLIA, and ELISA technologies.
Fully automated laboratory platforms ensuring standardized and reproducible results.
Selection of the most appropriate technology based on the clinical indication and test requirements.
High analytical sensitivity and specificity for autoimmune antibody detection.
Expert interpretation by experienced pathologists and laboratory professionals.
Strict internal and external quality assurance procedures.
Comprehensive Autoimmune Test Portfolio
Antinuclear Antibody (ANA) Testing
ANA Profile / Immunoblot
Anti-Cardiolipin Antibodies (IgG & IgM)
Anti-Phospholipid Antibodies
Anti-β2 Glycoprotein I Antibodies
Anti-Tissue Transglutaminase (tTG) IgA & IgG
Deamidated Gliadin Peptide (DGP) IgA & IgG
ENA Profile and disease-specific autoantibodies
Additional autoimmune and connective tissue disease markers.
Benefits of IDC’s Multi-Technology Approach
Combines sensitive screening with highly specific confirmatory testing where appropriate.
Supports early detection of autoimmune diseases.
Accurate qualitative and quantitative antibody measurements.
Improved diagnostic confidence through standardized automated testing.
Reliable results supporting diagnosis, prognosis, and treatment monitoring.
Clinical Applications
Systemic lupus erythematosus (SLE)
Sjögren syndrome
Systemic sclerosis (Scleroderma)
Mixed connective tissue disease (MCTD)
Antiphospholipid syndrome (APS)
Celiac disease
Autoimmune liver diseases
Autoimmune thyroid disorders
Rheumatologic and connective tissue disorders
Evaluation of patients with suspected autoimmune diseases.
Why Choose IDC?
IDC is ISO15189:2022 accredited laboratory.
Comprehensive autoimmune testing under one roof.
Advanced IFA, Immunoblotting, CLIA, and ELISA technologies.
Fully automated laboratory systems.
Experienced pathologists and laboratory scientists.
Stringent quality assurance and standardized workflows.
Accurate, reliable, and clinically actionable reports.
